Psych MEQs / SAQs · Public-community — military and veteran psychiatry
Recently transitioned combat veteran with nightmares, alcohol use, and passive death wishes (MEQ)
FRANZCP-style MEQ on military/veteran psychiatry: multi-domain formulation, weapons-aware risk assessment, landmark epidemiology, trauma-focused and pharmacotherapy care, and common pitfalls.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Formulation. Service is context, not diagnosis. Map combat Criterion A exposures to DSM-5-TR PTSD clusters (intrusion, avoidance, negative cognitions/mood, arousal) lasting more than 1 month with impairment. Alcohol may self-medicate hyperarousal and sleep loss. Moral injury (Litz) may add guilt/shame/betrayal themes that are formulation, not a separate DSM code. Transition stressors (identity, relationships, civilian role) maintain morbidity. Stigma ("I am not weak") is a barrier mechanism delaying care (Hoge framing).[1][3][10]
(ii) Assessment today. Explicit suicide assessment: ideation, intent, plan, means — firearm access and storage. Safety plan and means restriction. Screen violence/IPV and child protection if dependents. Trauma-informed service history (deployments, roles) without forcing graphic first-session retelling; private MST enquiry principle. Substance quantity and withdrawal risk. MSE and capacity. Measures: PCL-5 for severity monitoring; CAPS-5 when diagnostic precision needed. Collateral with consent.[10][1]
(iii) Epidemiology anchors. Hoge 2004: combat-related mental health burden and barriers to care. Fear 2010: UK armed forces deployment mental health consequences including PTSD symptoms and alcohol patterns. Seal 2007: high rates of mental health diagnoses among OEF/OIF veterans using VA care. Fulton 2015 meta-analysis estimates substantial OEF/OIF PTSD prevalence with heterogeneity — avoid false precision.[1][2][9]
(iv) Management. Safety and alcohol plan first. First-line trauma-focused psychotherapy: CPT (Monson veteran RCT) and PE with military psychotherapy synthesis (Steenkamp 2015) noting residual symptoms are common. If medication chosen: sertraline 25–50 mg orally daily, titrate toward 50–200 mg; monitor sexual dysfunction, GI effects, activation/suicidality. Prazosin for nightmares: counsel equipoise — 2013 active-duty positive trial versus 2018 multi-site veteran NEJM null; individualised trial if BP allows. Avoid benzodiazepine default for core trauma. Link veteran-competent services and family support.[4][5][6][7][8]
(v) Pitfalls and disposition. Pitfalls: assuming all veterans have PTSD; skipping weapons; ignoring moral injury; over-selling prazosin; inventing compensation statutes; treating alcohol as optional. Disposition: same-day senior review if high intent or unsafe firearm storage; crisis follow-up; trauma psychology for PE/CPT; primary care liaison; step-up for psychosis, severe withdrawal, or ongoing high risk.[7][10][5]
Common errors
Equating military service with automatic PTSD diagnosis; omitting firearm/means assessment; presenting prazosin as universally effective after 2018 null multi-site evidence; inventing DVA/VA statute section numbers; using family as sole historians without private MST-safe enquiry.[1][7][10]
References
- [1]Hoge CW, Castro CA, Messer SC, McGurk D, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care N Engl J Med, 2004.PMID 15229303
- [2]Fear NT, Jones M, Murphy D, Hull L, et al. What are the consequences of deployment to Iraq and Afghanistan on the mental health of the UK armed forces? A cohort study Lancet, 2010.PMID 20471076
- [3]Litz BT, Stein N, Delaney E, Lebowitz L, et al. Moral injury and moral repair in war veterans: a preliminary model and intervention strategy Clin Psychol Rev, 2009.PMID 19683376
- [4]Monson CM, Schnurr PP, Resick PA, Friedman MJ, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder J Consult Clin Psychol, 2006.PMID 17032094
- [5]Steenkamp MM, Litz BT, Hoge CW, Marmar CR Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials JAMA, 2015.PMID 26241600
- [6]Brady K, Pearlstein T, Asnis GM, Baker D, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial JAMA, 2000.PMID 10770145
- [7]Raskind MA, Peskind ER, Chow B, Harris C, et al. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans N Engl J Med, 2018.PMID 29414272
- [8]Raskind MA, Peterson K, Williams T, Hoff DJ, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan Am J Psychiatry, 2013.PMID 23846759
- [9]Seal KH, Bertenthal D, Miner CR, Sen S, Marmar C Bringing the war back home: mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities Arch Intern Med, 2007.PMID 17353495
- [10]Pompili M, Sher L, Serafini G, Forte A, et al. Posttraumatic stress disorder and suicide risk among veterans: a literature review J Nerv Ment Dis, 2013.PMID 23995037